NeuroOne Medical Technologies (NASDAQ:NMTC) Trading Down 9.1% – What’s Next?

NeuroOne Medical Technologies Co. (NASDAQ:NMTC)’s share price dropped 9.1% during trading on Thursday . The company traded as low as $0.72 and last traded at $0.76. Approximately 393,704 shares traded hands during trading, an increase of 196% from the average daily volume of 133,201 shares. The stock had previously closed at $0.84.

NeuroOne Medical Technologies Price Performance

The firm has a 50 day moving average of $0.83 and a two-hundred day moving average of $0.84. The firm has a market capitalization of $23.42 million, a price-to-earnings ratio of -1.58 and a beta of 0.54.

Institutional Investors Weigh In On NeuroOne Medical Technologies

A hedge fund recently raised its stake in NeuroOne Medical Technologies stock. Geode Capital Management LLC grew its stake in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC) by 9.6% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 283,855 shares of the company’s stock after buying an additional 24,972 shares during the quarter. Geode Capital Management LLC owned approximately 0.92% of NeuroOne Medical Technologies worth $281,000 as of its most recent SEC filing. Institutional investors and hedge funds own 16.07% of the company’s stock.

NeuroOne Medical Technologies Company Profile

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.